USA Monogenetic Disorders Testing Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Monogenetic Disorders Testing market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Monogenetic Disorders Testing market. Detailed analysis of key players, along with key growth strategies adopted by Monogenetic Disorders Testing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • PerkinElmer

    • ELITech Group

    • Thermo Fisher Scientific

    • Celera Group

    • AutoGenomics

    • Roche

    • Bio-Rad

    • Quest

    • Transgenomic

    • Abbott

    By Type:

    • Carrier Testing

    • Diagnostic Testing

    • New-Born Screening

    • Predictive & Pre-Symptomatic Testing

    • Prenatal Testing

    • Others

    By End-User:

    • Hospitals

    • Specialized Clinics

    • Ambulatory Surgical Centers

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Monogenetic Disorders Testing Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Monogenetic Disorders Testing Market Size and Growth Rate of Carrier Testing from 2016 to 2027

      • 1.3.2 USA Monogenetic Disorders Testing Market Size and Growth Rate of Diagnostic Testing from 2016 to 2027

      • 1.3.3 USA Monogenetic Disorders Testing Market Size and Growth Rate of New-Born Screening from 2016 to 2027

      • 1.3.4 USA Monogenetic Disorders Testing Market Size and Growth Rate of Predictive & Pre-Symptomatic Testing from 2016 to 2027

      • 1.3.5 USA Monogenetic Disorders Testing Market Size and Growth Rate of Prenatal Testing from 2016 to 2027

      • 1.3.6 USA Monogenetic Disorders Testing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Monogenetic Disorders Testing Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Monogenetic Disorders Testing Market Size and Growth Rate of Specialized Clinics from 2016 to 2027

      • 1.4.3 USA Monogenetic Disorders Testing Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Monogenetic Disorders Testing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Monogenetic Disorders Testing by Major Types

      • 3.4.1 Market Size and Growth Rate of Carrier Testing

      • 3.4.2 Market Size and Growth Rate of Diagnostic Testing

      • 3.4.3 Market Size and Growth Rate of New-Born Screening

      • 3.4.4 Market Size and Growth Rate of Predictive & Pre-Symptomatic Testing

      • 3.4.5 Market Size and Growth Rate of Prenatal Testing

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Monogenetic Disorders Testing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Monogenetic Disorders Testing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Monogenetic Disorders Testing in Hospitals

      • 4.4.2 Market Size and Growth Rate of Monogenetic Disorders Testing in Specialized Clinics

      • 4.4.3 Market Size and Growth Rate of Monogenetic Disorders Testing in Ambulatory Surgical Centers

    5 Market Analysis by Regions

    • 5.1 USA Monogenetic Disorders Testing Production Analysis by Regions

    • 5.2 USA Monogenetic Disorders Testing Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Monogenetic Disorders Testing Landscape Analysis

    • 6.1 West USA Monogenetic Disorders Testing Landscape Analysis by Major Types

    • 6.2 West USA Monogenetic Disorders Testing Landscape Analysis by Major End-Users

    7 South USA Monogenetic Disorders Testing Landscape Analysis

    • 7.1 South USA Monogenetic Disorders Testing Landscape Analysis by Major Types

    • 7.2 South USA Monogenetic Disorders Testing Landscape Analysis by Major End-Users

    8 Middle West USA Monogenetic Disorders Testing Landscape Analysis

    • 8.1 Middle West USA Monogenetic Disorders Testing Landscape Analysis by Major Types

    • 8.2 Middle West USA Monogenetic Disorders Testing Landscape Analysis by Major End-Users

    9 Northeast USA Monogenetic Disorders Testing Landscape Analysis

    • 9.1 Northeast USA Monogenetic Disorders Testing Landscape Analysis by Major Types

    • 9.2 Northeast USA Monogenetic Disorders Testing Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 PerkinElmer

        • 10.1.1 PerkinElmer Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 ELITech Group

        • 10.2.1 ELITech Group Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Thermo Fisher Scientific

        • 10.3.1 Thermo Fisher Scientific Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Celera Group

        • 10.4.1 Celera Group Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 AutoGenomics

        • 10.5.1 AutoGenomics Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Roche

        • 10.6.1 Roche Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Bio-Rad

        • 10.7.1 Bio-Rad Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Quest

        • 10.8.1 Quest Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Transgenomic

        • 10.9.1 Transgenomic Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Abbott

        • 10.10.1 Abbott Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Carrier Testing from 2016 to 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Diagnostic Testing from 2016 to 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of New-Born Screening from 2016 to 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Predictive & Pre-Symptomatic Testing from 2016 to 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Prenatal Testing from 2016 to 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Specialized Clinics from 2016 to 2027

    • Figure USA Monogenetic Disorders Testing Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Monogenetic Disorders Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Monogenetic Disorders Testing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Monogenetic Disorders Testing

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Monogenetic Disorders Testing by Different Types from 2016 to 2027

    • Table Consumption Share of Monogenetic Disorders Testing by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Carrier Testing

    • Figure Market Size and Growth Rate of Diagnostic Testing

    • Figure Market Size and Growth Rate of New-Born Screening

    • Figure Market Size and Growth Rate of Predictive & Pre-Symptomatic Testing

    • Figure Market Size and Growth Rate of Prenatal Testing

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Monogenetic Disorders Testing by Different End-Users from 2016 to 2027

    • Table Consumption Share of Monogenetic Disorders Testing by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Specialized Clinics

    • Figure Market Size and Growth Rate of Ambulatory Surgical Centers

    • Table USA Monogenetic Disorders Testing Production by Regions

    • Table USA Monogenetic Disorders Testing Production Share by Regions

    • Figure USA Monogenetic Disorders Testing Production Share by Regions in 2016

    • Figure USA Monogenetic Disorders Testing Production Share by Regions in 2021

    • Figure USA Monogenetic Disorders Testing Production Share by Regions in 2027

    • Table USA Monogenetic Disorders Testing Consumption by Regions

    • Table USA Monogenetic Disorders Testing Consumption Share by Regions

    • Figure USA Monogenetic Disorders Testing Consumption Share by Regions in 2016

    • Figure USA Monogenetic Disorders Testing Consumption Share by Regions in 2021

    • Figure USA Monogenetic Disorders Testing Consumption Share by Regions in 2027

    • Table West USA Monogenetic Disorders Testing Consumption by Types from 2016 to 2027

    • Table West USA Monogenetic Disorders Testing Consumption Share by Types from 2016 to 2027

    • Figure West USA Monogenetic Disorders Testing Consumption Share by Types in 2016

    • Figure West USA Monogenetic Disorders Testing Consumption Share by Types in 2021

    • Figure West USA Monogenetic Disorders Testing Consumption Share by Types in 2027

    • Table West USA Monogenetic Disorders Testing Consumption by End-Users from 2016 to 2027

    • Table West USA Monogenetic Disorders Testing Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Monogenetic Disorders Testing Consumption Share by End-Users in 2016

    • Figure West USA Monogenetic Disorders Testing Consumption Share by End-Users in 2021

    • Figure West USA Monogenetic Disorders Testing Consumption Share by End-Users in 2027

    • Table South USA Monogenetic Disorders Testing Consumption by Types from 2016 to 2027

    • Table South USA Monogenetic Disorders Testing Consumption Share by Types from 2016 to 2027

    • Figure South USA Monogenetic Disorders Testing Consumption Share by Types in 2016

    • Figure South USA Monogenetic Disorders Testing Consumption Share by Types in 2021

    • Figure South USA Monogenetic Disorders Testing Consumption Share by Types in 2027

    • Table South USA Monogenetic Disorders Testing Consumption by End-Users from 2016 to 2027

    • Table South USA Monogenetic Disorders Testing Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Monogenetic Disorders Testing Consumption Share by End-Users in 2016

    • Figure South USA Monogenetic Disorders Testing Consumption Share by End-Users in 2021

    • Figure South USA Monogenetic Disorders Testing Consumption Share by End-Users in 2027

    • Table Middle West USA Monogenetic Disorders Testing Consumption by Types from 2016 to 2027

    • Table Middle West USA Monogenetic Disorders Testing Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Monogenetic Disorders Testing Consumption Share by Types in 2016

    • Figure Middle West USA Monogenetic Disorders Testing Consumption Share by Types in 2021

    • Figure Middle West USA Monogenetic Disorders Testing Consumption Share by Types in 2027

    • Table Middle West USA Monogenetic Disorders Testing Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Monogenetic Disorders Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Monogenetic Disorders Testing Consumption Share by End-Users in 2016

    • Figure Middle West USA Monogenetic Disorders Testing Consumption Share by End-Users in 2021

    • Figure Middle West USA Monogenetic Disorders Testing Consumption Share by End-Users in 2027

    • Table Northeast USA Monogenetic Disorders Testing Consumption by Types from 2016 to 2027

    • Table Northeast USA Monogenetic Disorders Testing Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Monogenetic Disorders Testing Consumption Share by Types in 2016

    • Figure Northeast USA Monogenetic Disorders Testing Consumption Share by Types in 2021

    • Figure Northeast USA Monogenetic Disorders Testing Consumption Share by Types in 2027

    • Table Northeast USA Monogenetic Disorders Testing Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Monogenetic Disorders Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Monogenetic Disorders Testing Consumption Share by End-Users in 2016

    • Figure Northeast USA Monogenetic Disorders Testing Consumption Share by End-Users in 2021

    • Figure Northeast USA Monogenetic Disorders Testing Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of PerkinElmer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PerkinElmer

    • Figure Sales and Growth Rate Analysis of PerkinElmer

    • Figure Revenue and Market Share Analysis of PerkinElmer

    • Table Product and Service Introduction of PerkinElmer

    • Table Company Profile and Development Status of ELITech Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ELITech Group

    • Figure Sales and Growth Rate Analysis of ELITech Group

    • Figure Revenue and Market Share Analysis of ELITech Group

    • Table Product and Service Introduction of ELITech Group

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Celera Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celera Group

    • Figure Sales and Growth Rate Analysis of Celera Group

    • Figure Revenue and Market Share Analysis of Celera Group

    • Table Product and Service Introduction of Celera Group

    • Table Company Profile and Development Status of AutoGenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AutoGenomics

    • Figure Sales and Growth Rate Analysis of AutoGenomics

    • Figure Revenue and Market Share Analysis of AutoGenomics

    • Table Product and Service Introduction of AutoGenomics

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Bio-Rad

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad

    • Figure Sales and Growth Rate Analysis of Bio-Rad

    • Figure Revenue and Market Share Analysis of Bio-Rad

    • Table Product and Service Introduction of Bio-Rad

    • Table Company Profile and Development Status of Quest

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest

    • Figure Sales and Growth Rate Analysis of Quest

    • Figure Revenue and Market Share Analysis of Quest

    • Table Product and Service Introduction of Quest

    • Table Company Profile and Development Status of Transgenomic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transgenomic

    • Figure Sales and Growth Rate Analysis of Transgenomic

    • Figure Revenue and Market Share Analysis of Transgenomic

    • Table Product and Service Introduction of Transgenomic

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.